Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in ...

There are 20 cell and gene therapies on Europe's market versus 43 in the U.S. Find out more about this ecosystem.

In this review of RNA therapies, we paint an overview of what’s going on in a field that is addressing a number of diseases.

Various PD-1 and PD-L1 checkpoint inhibitors have been approved by U.S. regulators including blockbuster drugs Keytruda, Imfinzi, and Opdivo to treat different types of cancer. But that hasn’t stopped ...